Biomechanics Corporation of America Appoints Julian H. Cherubini to Board of Directors

Strategic Insights

Apr 16, 1995 — 1 min read

Julian H. Cherubini, a seasoned executive with a rich background in orthotics and ergonomic products, has joined the Board of Directors of Biomechanics Corporation of America. Founded in 1970, AliMed, a company Cherubini founded, is a leading manufacturer and distributor of products for orthopedic rehabilitation, diagnostic imaging, and occupational medicine. As an expert in metallurgy, nuclear, and low energy physics, Cherubini has received numerous patents in the orthotics field and has held various sales and market development positions in the industry.

Key Takeaways:

Julian H. Cherubini, President and CEO of AliMed, has been elected to the Board of Directors of Biomechanics Corporation of America.
Cherubini has extensive experience in the orthotics and ergonomic products industry, with over 25 years of experience, including founding AliMed in 1970.
AliMed is a leading manufacturer and distributor of products for orthopedic rehabilitation, diagnostic imaging, operating rooms, occupational medicine, and ergonomics.
Cherubini holds a BS in Metallurgy from MIT and an MS in Materials and Radiochemistry from the University of Tennessee at Oak Ridge.
He has received numerous patents in the orthotics field and has held various sales and market development positions in the industry, including eight years at High Voltage Engineering.

Statistics:

Cherubini has over 25 years of experience in the orthotics and ergonomic products industry.
AliMed, a company Cherubini founded, has been in operation since 1970.
Cherubini holds a BS in Metallurgy from MIT and an MS in Materials and Radiochemistry from the University of Tennessee at Oak Ridge.
AliMed is a manufacturer and distributor of a wide range of products for orthopedic rehabilitation, diagnostic imaging, and occupational medicine.

Sources:

Michael Strauss, Chairman of the Board of Biomechanics Corporation of America (April 17, 1995)
Biomechanics Corporation of America (April 17, 1995)
Strategic Growth International Stanley Altschuler, 516/829-7111 (April 17, 1995)

The End of American Hypergrowth

For two centuries, the US economy grew by adding workers. That's over.

Healthcare's $5.3 Trillion Drag

How Medical Spending Became America's Biggest Productivity Tax

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Researchers at the Wuhan University of Technology in China have made significant progress in the field of nanotechnology, specifically in the area of nanoindentation. A novel electromagnetic shock treatment (EST) method has been developed to enhance the microscale mechanical properties of a titanium alloy, with promising results obtained through array-based

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients

Research investigators at the Zhengzhou Central Hospital Affiliated to Zhengzhou University have made groundbreaking discoveries on the role of gut microbiota in determining the efficacy of immunotherapy for colon cancer patients. The study, which was recently published in Biochimica et Biophysica Acta, reveals that specific bacterial species and microbial metabolites

Read more

The End of American Hypergrowth

Healthcare's $5.3 Trillion Drag

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients